Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$4.19 - $6.23 $65,016 - $96,670
-15,517 Reduced 28.21%
39,498 $179,000
Q1 2024

May 14, 2024

SELL
$5.69 - $8.08 $421,162 - $598,065
-74,018 Reduced 57.36%
55,015 $331,000
Q4 2023

Feb 12, 2024

SELL
$3.77 - $8.39 $70,540 - $156,985
-18,711 Reduced 12.66%
129,033 $1.03 Million
Q3 2023

Nov 14, 2023

BUY
$5.2 - $8.77 $18,777 - $31,668
3,611 Added 2.51%
147,744 $957,000
Q2 2023

Aug 14, 2023

SELL
$5.86 - $7.93 $10,923 - $14,781
-1,864 Reduced 1.28%
144,133 $866,000
Q1 2023

May 15, 2023

BUY
$5.85 - $9.84 $78,384 - $131,846
13,399 Added 10.1%
145,997 $903,000
Q4 2022

Feb 14, 2023

BUY
$6.88 - $9.55 $350,969 - $487,174
51,013 Added 62.53%
132,598 $1.22 Million
Q3 2022

Nov 14, 2022

BUY
$8.19 - $13.2 $204,774 - $330,039
25,003 Added 44.19%
81,585 $772,000
Q2 2022

Aug 15, 2022

SELL
$7.65 - $14.24 $141,662 - $263,696
-18,518 Reduced 24.66%
56,582 $575,000
Q1 2022

May 13, 2022

SELL
$13.02 - $20.78 $208,320 - $332,480
-16,000 Reduced 17.56%
75,100 $1.07 Million
Q4 2021

Feb 11, 2022

BUY
$19.35 - $25.54 $81,270 - $107,268
4,200 Added 4.83%
91,100 $1.88 Million
Q3 2021

Nov 12, 2021

BUY
$21.65 - $39.49 $532,590 - $971,454
24,600 Added 39.49%
86,900 $1.98 Million
Q1 2021

May 17, 2021

SELL
$14.84 - $22.23 $56,392 - $84,474
-3,800 Reduced 5.75%
62,300 $1.26 Million
Q4 2020

Feb 03, 2021

SELL
$9.4 - $16.7 $77,080 - $136,940
-8,200 Reduced 11.04%
66,100 $1 Million
Q3 2020

Nov 16, 2020

BUY
$10.54 - $24.96 $256,121 - $606,528
24,300 Added 48.6%
74,300 $783,000
Q2 2020

Aug 12, 2020

BUY
$21.87 - $33.11 $69,984 - $105,952
3,200 Added 6.84%
50,000 $1.22 Million
Q1 2020

May 06, 2020

BUY
$16.25 - $35.28 $521,625 - $1.13 Million
32,100 Added 218.37%
46,800 $1.13 Million
Q3 2019

Nov 12, 2019

BUY
$14.42 - $22.2 $211,974 - $326,340
14,700 New
14,700 $212,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $149M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.